Related Experiment Video
Updated: Sep 2, 2025

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Wnt3a/YTHDF1 Regulated Oxaliplatin-Induced Neuropathic Pain Via TNF-α/IL-18 Expression in the Spinal Cord
Xiaohui Bai1, Yongtian Huang2, Wan Huang2
1Department of Anesthesiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang Road West, Guangzhou, China.
Abstract:
Oxaliplatin is widely used in cancer treatment, however, many patients will suffer from neuropathic pain (NP) induced by it at the same time. Therefore exploring the mechanism and founding novel target for this problem are needed. In this study, YTHDF1 showed upregulation in oxaliplatin treated mice. As m6A is known as conserved and it widely functions in numerous physiological and pathological processes. Therefore, we focused on exploring the molecular mechanism of whether and how YTHDF1 functions in NP induced by oxaliplatin. IHC and western blotting were conducted to measure proteins. Intrathecal injection for corresponding siRNAs in C57/BL6 mice or spinal microinjection for virus in YTHDF1flox/flox mice were applied to specially knockdown the expression of molecular. Von Frey, acetone test and ethyl chloride (EC) test were applied to evaluate NP behavior. YTHDF1, Wnt3a, TNF-α and IL-18 were increased in oxaliplatin treated mice, restricted the molecular mentioned above respectively can significantly attenuate oxaliplatin-induced NP, including the mechanical allodynia and cold allodynia. Silencing YTHDF1 and inhibiting Wnt3a and Wnt signaling pathways can reduce the enhancement of TNF-α and IL-18, and the decreasing of the upregulation of YTHDF1 can be found when inhibiting Wnt3a and Wnts signaling pathways in oxaliplatin treated mice. Our study indicated a novel pathway that can contribute to oxaliplatin-induced NP, the Wnt3a/YTHDF1 to cytokine pathway, which upregulating YTHDF1 functioned as the downstream of Wnt3a signal and promoted the translation of TNF-α and IL-18 in oxaliplatin treated mice.
Insights
Oxaliplatin chemotherapy can cause neuropathic pain (NP). This study reveals YTHDF1 upregulation promotes NP by activating Wnt3a signaling, leading to increased TNF-α and IL-18, offering new therapeutic targets for NP.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- Oxaliplatin is a crucial chemotherapy agent, but it frequently induces neuropathic pain (NP).
- Understanding the molecular mechanisms behind oxaliplatin-induced NP is essential for developing effective pain management strategies.
- YTHDF1, a key mediator in RNA modification, has emerged as a potential player in pathological processes.
Purpose of the Study:
- To investigate the role of YTHDF1 in the development of oxaliplatin-induced neuropathic pain (NP).
- To elucidate the molecular pathway involving YTHDF1 in this pain model.
- To identify potential therapeutic targets for mitigating oxaliplatin-induced NP.
Main Methods:
- Utilized immunohistochemistry and Western blotting to assess protein expression in mice.
- Employed intrathecal siRNA injection and viral spinal microinjection in YTHDF1flox/flox mice for gene knockdown.
- Assessed neuropathic pain behaviors using Von Frey, acetone, and ethyl chloride tests.
Main Results:
- YTHDF1, Wnt3a, TNF-α, and IL-18 were significantly upregulated in mice treated with oxaliplatin.
- Targeted inhibition of YTHDF1, Wnt3a, or downstream signaling pathways attenuated mechanical and cold allodynia.
- Silencing YTHDF1 or inhibiting Wnt3a/Wnt signaling reduced TNF-α and IL-18 levels.
Conclusions:
- YTHDF1 plays a critical role in mediating oxaliplatin-induced neuropathic pain.
- A novel Wnt3a/YTHDF1-cytokine pathway contributes to NP pathogenesis.
- YTHDF1 acts downstream of Wnt3a signaling to promote TNF-α and IL-18 translation, presenting a potential therapeutic target.
Related Concept Videos
Analgesia and Pain Management
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Nociception
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

